GENinCode Plc (AIM:GENI)
London
· Delayed Price · Currency is GBP · Price in GBX 2.450
-0.050 (-2.00%)
Apr 17, 2025, 5:07 PM GMT+1
GENinCode Revenue
GENinCode had revenue of 1.39M GBP in the half year ending June 30, 2024, with 109.19% growth. This brings the company's revenue in the last twelve months to 2.60M, up 51.46% year-over-year. In the year 2023, GENinCode had annual revenue of 2.16M with 51.05% growth.
Revenue (ttm)
2.60M
Revenue Growth
+51.46%
P/S Ratio
2.70
Revenue / Employee
61.88K
Employees
42
Market Cap
7.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.16M | 730.00K | 51.05% |
| Dec 31, 2022 | 1.43M | 276.00K | 23.92% |
| Dec 31, 2021 | 1.15M | 193.00K | 20.08% |
| Dec 31, 2020 | 961.00K | -480.49K | -33.33% |
| Dec 31, 2019 | 1.44M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
GENinCode News
- 2 months ago - AIM Market Roundup: Good Energy, Beacon Energy, Abingdon Health - The Armchair Trader
- 3 months ago - AIM Market Roundup: GENinCode, Empyrean, Watkins Jones - The Armchair Trader
- 7 months ago - Half Year 2024 Genincode PLC Earnings Presentation Transcript - GuruFocus
- 7 months ago - Half Year 2024 Genincode PLC Earnings Presentation (Shareholder Q&A) Transcript - GuruFocus